Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-874-0 | CAS number: 100-64-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral LD50 of cyclohexanone oxime (CHO) was 883 mg/kg bw in female and 1765 mg/kg bw in male rats, respectively.
No information is available for the inhalation route.
The dermal LD50 in rabbits was > 5000 mg/kg bw.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 30. Jan 1979 to 28. Feb 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Similar to guideline OECD 401 with acceptable restrictions, limited documentation
- Qualifier:
- according to guideline
- Guideline:
- other: EPA guideline (not further specified)
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: CHarles River Breeding Laboratory, Wilmington, USA
- Weight at study initiation: 145-236 g (males) and 138-163 g (females)
- Fasting period before study: overnight
- Housing: groups of two
- Diet (ad libitum): Purina laboratory chow
- Water (ad libitum): source not stated
- Acclimation period: 7 days - Route of administration:
- oral: gavage
- Vehicle:
- not specified
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 5000 mg/kg
- Doses:
- males: 562, 794, 1000, 1410, 1590, 2000 and 5000 mg/kg
females: 398, 631, 1000, 2000 and 5000 mg/kg - No. of animals per sex per dose:
- 10
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing:clinical observations immediately after dosing, then after 1 and 4 h, and twice daily thereafter
- Necropsy of survivors performed: yes - Statistics:
- Probit analysis according to Finney
- Sex:
- male
- Dose descriptor:
- LD50
- Effect level:
- 1 765.01 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 1 632 - 1 908.62
- Remarks on result:
- other: Acc. to study report: data obtained excluding the results of the 1000 mg/kg group; including this group the LD50 was 1758.94 (95% CI: 1374.74-2250.52) mg/kg
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 882.82 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- 725.88 - 1 073.69
- Mortality:
- Mortality in males:
562 mg/kg: 0
794 mg/kg: 0
1000 mg/kg: 3
1410 mg/kg: 0
1590 mg/kg: 3
2000 mg/kg: 8
5000 mg/kg: 10
Mortality in females:
398 mg/kg: 0
631 mg/kg: 2
1000 mg/kg: 6
2000 mg/kg: 10
5000 mg/kg: 10 - Clinical signs:
- Surviving animals: transient slight to marked depression, rough hair coat, salivation, urine stains, ataxia in all dose groups for 1 - 4 h after administration (up to 2 days at higher doses)
labored respiration, prostration before death - Body weight:
- not recorded
- Gross pathology:
- Discoloration of the spleen was noted in ten male rats dosed at 794 mg/kg of body weight, and in seven males dosed a t the 1590 mg/kg level. Discoloration of the stomach and/or intestines was observed in two males dosed a t the1000 mg/kg level, two males dosed at the 1590 mg/kg level, and four females dosed at 2000 mg/kg of body weight. Dark fluid was observed in the stomach and/or intestines of one male dosed a t 1000 mg/kg of body weight, three males dosed at the 1590 mg/kg level, one female dosed at the 631 mg/kg level, and three females dosed at the 1000 mg/kg level. Compound was noted in the stomach and/or intestines of two males dosed at the 1590 mg/kg level, in seven males and nine females dosed at the 2000 mg/kg level, and in all ten males and females dosed a t the 5000 mg/kg level.
- Interpretation of results:
- Toxicity Category IV
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study the test substance the LD50 in rats was 883 mg/kg bw for females and 1765 mg/kg bw for males. Therefore the substance has to be classified as harmful if swallowed according to Regulation (EC) No 1272/2008
- Executive summary:
The test substance was evaluated for acute oral toxicity in male and female Fischer 344 rats in a study performed according to EPA guidelines (similar to guideline OECD 401). Groups of 10 animals per sex were exposed to 562, 794, 1000, 1410, 1590, 2000 or 5000 mg/kg (males) or 398, 631, 1000, 2000 or 5000 mg/kg (females). After exposure the animals were observed for 14 days. Surviving animals showed transient slight to marked depression, rough hair coat, salivation, urine stains, and ataxia in all dose groups for 1 - 4 h after administration (up to 2 days at higher doses). Labored respiration and prostration was evident before death. Based upon the findings of this study, the acute oral LD50 was calculated to be 1765.01 and 882.82 mg/kg bw, with 95% confidence limits for males from 1632.20 to 1908.62 mg/kg bw and for females from 725.88 to 1073.69 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 882 mg/kg bw
- Quality of whole database:
- reliable LD50 in female rats
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1985
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Equivalent to guidellne with limited documentation
- Reason / purpose for cross-reference:
- reference to same study
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- additional: haematology performed
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- New Zealand White
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Davidson Mill Farms, NJ, USA
- Acclimation period: at least 14 days - Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- Exposure to back skin shaved 24 h prior to application
- Duration of exposure:
- 24 h
- Doses:
- 0, 0.8, 2 or 5 g/kg bw
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: clinical observations: daily; weighing: days -14, -7, 0 (day of exposure), 1, 4, 7, 14
- Necropsy of survivors performed: yes
- Other examinations performed: spleen weights determined at end of study, blood was taken on days 1, 4 and 7 and haematology was performed - Statistics:
- no data
- Sex:
- male/female
- Dose descriptor:
- approximate LD50
- Effect level:
- > 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- not observed
- Clinical signs:
- not observed
- Body weight:
- not altered
- Gross pathology:
- no effects observed
- Other findings:
- - Organ weights: no effects on spleen weight
- Potential target organs: blood
- Other observations: haematology: dose-related increase in reticulocyte counts in both sexes, statistically significant only in males at highest dose, further effects: dose-related decrease in haemoglobin in females, significant at highest dose on day 7; dose-related increase in methaemoglobin in both sexes at day 4 - Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of this study the dermal LD50 was > 5000 mg/kg bw. No classification is required.
- Executive summary:
New Zealand white rabbits (5 per sex and dose) were tested for acute dermal toxicity in a study equilvalent to guideline OECD 402. They were exposed to 0, 800, 2000 or 5000 mg/kg bw of the test substance dermally for 24 h under an occlusive patch and observed for 14 days. No animal died at any dose level. There were no adverse clinical signs, body weight or organ weight changes associated with treatment. Haematological effects (all dose-related: increased reticulocyte counts, significant at highest dose only in in males; decreased haemoglobin values in females, significant at highest dose on day 7; increased methemoglobin levels in both sexes at day 4) indicate systemic uptake of the test substance.
Under the conditions of this study the dermal LD50 was > 5000 mg/kg bw.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- reliable LD50 > 5000 mg/kg bw
Additional information
Oral exposure
Based on a reliable study (according to EPA guidelines, similar to guideline OECD 401, RL2) in male and female rats, the acute oral LD50 was calculated to be 1765.01 mg/kg bw (95% confidence interval 1632.20 to 1908.62 mg/kg bw) in males and 882.82 mg/kg bw (725.88 to 1073.69 mg/kg bw) in females. Support comes from a reliable study by Derelanko et al. (1985) with subacute exposure duration (10 exposures within 14 days), where no mortality was observed at doses up to 300 mg/kg bw/day, the highest dose tested.
Inhalation exposure
This information is not available. In accordance with column 2 of section 8.5 of REACH Annex VIII, an acute inhalation toxicity study is not necessary, because information is available for the oral and dermal route.
Dermal exposure
No mortality was observed after acute dermal exposure of rabbits in a reliable study (similar to OECD guideline 402, RL2) with doses up to 5000 mg/kg bw. Thus the dermal LD50 was > 5000 mg/kg bw.
Justification for selection of acute toxicity – oral endpoint
reliable study (Klimisch 2)
Justification for selection of acute toxicity – dermal endpoint
reliable study (Klimisch 2)
Justification for classification or non-classification
Oral LD50 values for male and female rats lie within the range of 300-2000 mg/kg bw. Therefore, CHO has to be classified for acute toxicity according to Regulation (EC) 1272/2008 as “harmful if swallowed” (H302).
No information is available for inhalation exposure.
No classification is required for dermal exposure because the LD50 was > 5000 mg/kg bw.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.